tiprankstipranks
Trending News
More News >
M. Yochananof & Sons (1988) Ltd. (IL:YHNF)
:YHNF
Israel Market

Yochananof (YHNF) AI Stock Analysis

Compare
1 Followers

Top Page

IL:YHNF

Yochananof

(YHNF)

Select Model
Select Model
Select Model
Neutral 66 (OpenAI - 5.2)
Rating:66Neutral
Price Target:
41,045.00
▲(21.80% Upside)
Action:DowngradedDate:12/20/25
Yochananof's strong financial performance and positive technical indicators are offset by its high valuation and overbought technical conditions. The company's solid revenue growth and profitability are significant strengths, but the high P/E ratio and overbought signals suggest caution. Investors should monitor for any potential pullback or changes in market conditions.
Positive Factors
Revenue Growth
Sustained TTM revenue growth of ~13% signals durable demand expansion across stores and channels. Over a 2–6 month horizon this supports scale economies, stronger supplier terms, and continued reinvestment in stores and online, underpinning long-term top-line momentum.
Return on Equity
ROE of 13.5% indicates the company efficiently converts equity into profits relative to peers. This level of return supports reinvestment and dividend capacity, reflecting durable operational effectiveness and managerial allocation of capital over multiple quarters.
Free Cash Flow Growth
FCF growth of ~5% TTM shows improving cash generation, enhancing capacity to fund capex, service debt, and finance working capital without dilutive financing. Over months this strengthens financial flexibility and supports strategic investments in operations and e-commerce.
Negative Factors
Moderate Leverage
A debt/equity ratio of 1.31 signals meaningful reliance on debt financing. In a rising-rate or profit-challenged environment this leverage can constrain investment choices, increase interest expense sensitivity, and reduce resilience to macro shocks across the next several quarters.
Margin Pressure
Reported slight margin declines indicate creeping cost pressures or competitive pricing tradeoffs. If persistent, margin erosion will reduce free cash flow and profitability, forcing either price increases that risk volume or structural cost cuts that may harm service and growth.
Cash Conversion Gap
A FCF/net income ratio under 1 and operating cash flow only ~36% of net income highlight earnings not fully converting to cash. This gap constrains ability to deleverage or invest without external funding and raises risk during earnings or working-capital swings.

Yochananof (YHNF) vs. iShares MSCI Israel ETF (EIS)

Yochananof Business Overview & Revenue Model

Company DescriptionYochananof (YHNF) is a prominent retail chain based in Israel, specializing in grocery and supermarket operations. The company operates a network of stores offering a wide range of products, including fresh produce, dairy, meat, bakery items, and household goods. YHNF focuses on providing high-quality products and exceptional customer service, catering to the diverse needs of its local community while also emphasizing sustainability and local sourcing.
How the Company Makes MoneyYochananof generates revenue primarily through the sale of groceries and related products in its retail stores. The company operates on a traditional retail model, earning money from direct product sales to consumers. Key revenue streams include in-store purchases, online grocery orders, and delivery services. Additionally, YHNF may benefit from partnerships with local farmers and suppliers, which can enhance product offerings and support local economies. Seasonal promotions, loyalty programs, and value-added services, such as catering and meal kits, also contribute to revenue growth. The company might leverage its brand reputation and customer loyalty to drive repeat business, increasing overall sales.

Yochananof Financial Statement Overview

Summary
Yochananof demonstrates strong revenue growth and profitability, with stable financial metrics. The company faces challenges in maintaining margins and managing leverage, but overall, it remains in a solid financial position. Continued focus on cost management and cash flow optimization will be crucial for sustaining growth and financial health.
Income Statement
75
Positive
Yochananof's income statement shows a solid revenue growth trajectory, with a TTM revenue growth rate of 13.32%. The company maintains healthy profitability margins, including a gross profit margin of 19.40% and a net profit margin of 4.17% for the TTM. However, there is a slight decline in margins compared to the previous year, indicating potential cost pressures or competitive pricing strategies.
Balance Sheet
70
Positive
The balance sheet reflects a stable financial position with a debt-to-equity ratio of 1.31, indicating moderate leverage. The return on equity is 13.54%, showcasing efficient use of equity to generate profits. However, the equity ratio is relatively low, suggesting a higher reliance on debt financing, which could pose risks in a rising interest rate environment.
Cash Flow
68
Positive
Yochananof's cash flow statement reveals a positive free cash flow growth of 5.11% in the TTM, indicating improved cash generation. The operating cash flow to net income ratio is 0.36, suggesting adequate cash flow generation relative to net income. However, the free cash flow to net income ratio of 0.68 indicates that a significant portion of earnings is not translating into free cash flow, which may impact future investments or debt repayments.
BreakdownTTMMar 2025Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue4.86B4.60B4.09B3.72B3.49B3.12B
Gross Profit814.98M1.02B1.11B1.02B941.52M831.38M
EBITDA573.72M594.09M480.65M419.99M479.23M373.95M
Net Income187.90M210.35M139.31M126.46M210.32M127.27M
Balance Sheet
Total Assets4.41B4.19B3.98B3.80B3.35B2.66B
Cash, Cash Equivalents and Short-Term Investments381.77M346.18M326.57M330.50M464.99M229.32M
Total Debt1.87B1.87B1.81B1.78B1.32B1.27B
Total Liabilities2.87B2.68B2.55B2.45B2.00B1.85B
Stockholders Equity1.52B1.48B1.40B1.32B1.33B810.51M
Cash Flow
Free Cash Flow255.75M297.32M179.51M-324.43M78.95M149.95M
Operating Cash Flow376.98M433.02M358.80M310.20M331.49M311.26M
Investing Cash Flow-72.11M-140.97M-179.82M-602.15M-297.89M-171.39M
Financing Cash Flow-244.12M-272.43M-182.91M157.47M202.07M-91.79M

Yochananof Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price33700.00
Price Trends
50DMA
37220.80
Negative
100DMA
33860.52
Positive
200DMA
31360.72
Positive
Market Momentum
MACD
-2.97
Positive
RSI
41.23
Neutral
STOCH
16.60
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:YHNF, the sentiment is Neutral. The current price of 33700 is below the 20-day moving average (MA) of 37509.50, below the 50-day MA of 37220.80, and above the 200-day MA of 31360.72, indicating a neutral trend. The MACD of -2.97 indicates Positive momentum. The RSI at 41.23 is Neutral, neither overbought nor oversold. The STOCH value of 16.60 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IL:YHNF.

Yochananof Peers Comparison

Overall Rating
UnderperformOutperform
Sector (55)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
76
Outperform
₪3.91B17.813.06%9.97%15.86%
73
Outperform
₪3.35B9.284.18%8.53%39.35%
70
Outperform
₪5.44B20.254.01%6.10%-9.48%
67
Neutral
₪11.87B17.8017.20%4.88%-6.86%6.82%
66
Neutral
₪5.23B25.602.33%7.38%-7.10%
57
Neutral
₪7.36B111.820.46%44.88%21.45%
55
Neutral
$13.29B17.4210.03%0.93%7.13%-12.93%
* Services Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IL:YHNF
Yochananof
36,970.00
13,941.71
60.54%
IL:SAE
Shufersal
4,520.00
762.22
20.28%
IL:NTML
Neto Malinda
17,340.00
8,184.11
89.39%
IL:RMLI
Rami Levi
40,000.00
14,769.61
58.54%
IL:MAXO
Max Stock
2,900.00
1,673.31
136.41%
IL:TRPZ
Turpaz
6,728.00
4,142.00
160.17%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 20, 2025